FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
10,781 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coatedOral | Medcore LLC | ANDA | 82461-716 | 82461-0716-90 | — |
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coatedOral | Proficient Rx LP | ANDA | 82804-259 | 82804-0259-2082804-0259-3082804-0259-60+2 more | — |
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 5 mg/1 | Tablet, Film coatedOral | Northwind Health Company, LLC | ANDA | 82868-008 | 82868-0008-30 | — |
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coated |
| PHOENIX RX LLC |
| ANDA |
| 85509-1014 |
| 85509-1014-0385509-1014-0685509-1014-09 |
| — |
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 15 mg/1 | Capsule, Extended releaseOral | PHOENIX RX LLC | ANDA | 85509-1035 | 85509-1035-0385509-1035-0685509-1035-09 | — |
|---|
| Cyclobenzaprine hydrochloride | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coatedOral | PHOENIX RX LLC | ANDA | 85509-1415 | 85509-1415-0385509-1415-0685509-1415-09 | — |
|---|
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 15 mg/1 | Capsule, Extended releaseOral | PHOENIX RX LLC | NDA authorized generic | 85509-1920 | 85509-1920-0385509-1920-0685509-1920-09 | — |
|---|
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 5 mg/1 | Tablet, Film coatedOral | HAWAII REPACK, INC. | ANDA | 85534-0005 | 85534-0005-0085534-0005-0185534-0005-02+1 more | — |
|---|
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 7.5 mg/1 | Tablet, Film coatedOral | HAWAII REPACK, INC. | ANDA | 85534-0085 | 85534-0085-0085534-0085-0185534-0085-02+1 more | — |
|---|
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coatedOral | HAWAII REPACK, INC. | ANDA | 85534-0086 | 85534-0086-0085534-0086-0185534-0086-02+1 more | — |
|---|
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coatedOral | Sportpharm LLC | ANDA | 85766-003 | 85766-0003-0085766-0003-0185766-0003-02+11 more | — |
|---|
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coatedOral | Sportpharm LLC | ANDA | 85766-041 | 85766-0041-0085766-0041-0185766-0041-02+13 more | — |
|---|
| Cyclobenzaprine hydrochloride | Cyclobenzaprine hydrochloride 5 mg/1 | Tablet, Film coatedOral | Sportpharm LLC | ANDA | 85766-272 | 85766-0272-0185766-0272-1085766-0272-14+5 more | — |
|---|
| Cyclobenzaprine hydrochloride | Cyclobenzaprine hydrochloride 7.5 mg/1 | Tablet, Film coatedOral | Sportpharm LLC | ANDA | 85766-273 | 85766-0273-0185766-0273-1085766-0273-14+5 more | — |
|---|
| Cyclobenzaprine hydrochloride | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coatedOral | Sportpharm LLC | ANDA | 85766-274 | 85766-0274-0185766-0274-1085766-0274-14+5 more | — |
|---|
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coatedOral | Unit Dose Solutions, Inc. | ANDA | 87441-010 | 87441-0010-01 | — |
|---|
| Cyclogylcyclopentolate hydrochloride | Cyclopentolate hydrochloride 5 mg/mL | Solution/ dropsOphthalmic | Alcon Laboratories, Inc. | ANDA | 0065-0395 | 00065-0395-15 | — |
|---|
| Cyclogylcyclopentolate hydrochloride | Cyclopentolate hydrochloride 10 mg/mL | Solution/ dropsOphthalmic | Alcon Laboratories, Inc. | ANDA | 0065-0396 | 00065-0396-0200065-0396-05 | — |
|---|
| Cyclogylcyclopentolate hydrochloride | Cyclopentolate hydrochloride 20 mg/mL | Solution/ dropsOphthalmic | Alcon Laboratories, Inc. | ANDA | 0065-0397 | 00065-0397-0200065-0397-0500065-0397-15 | — |
|---|
| Cyclomydrilcyclopentolate hydrochloride and phenylephrine hydrochloride | Cyclopentolate hydrochloride 2 mg/mL; Phenylephrine hydrochloride 10 mg/mL | Solution/ dropsOphthalmic | Alcon Laboratories, Inc. | ANDA | 0065-0359 | 00065-0359-0200065-0359-05 | — |
|---|
| Cyclopentolate Hydrochloride | Cyclopentolate hydrochloride 10 mg/mL | Solution/ dropsOphthalmic | Bausch & Lomb Incorporated | ANDA | 24208-735 | 24208-0735-0124208-0735-06 | — |
|---|
| Cyclopentolate Hydrochloride | Cyclopentolate hydrochloride 10 mg/mL | SolutionOphthalmic | Sandoz Inc. | ANDA | 61314-396 | 61314-0396-0161314-0396-0261314-0396-03 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 25 mg/1 | CapsuleOral | Hikma Pharmaceuticals USA Inc. | NDA | 0054-0382 | 00054-0382-25 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 50 mg/1 | CapsuleOral | Hikma Pharmaceuticals USA Inc. | NDA | 0054-0383 | 00054-0383-25 | — |
|---|
| Cyclophosphamidecyclophosphamide injection, solution | Cyclophosphamide 200 mg/mL | InjectionIntravenous | Baxter Healthcare Company | NDA | 0338-9777 | 00338-9777-01 | — |
|---|
| Cyclophosphamidecyclophosphamide injection, solution | Cyclophosphamide 200 mg/mL | InjectionIntravenous | Baxter Healthcare Company | NDA | 0338-9779 | 00338-9779-01 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 500 mg/25mL | Injection, Powder, For solutionIntravenous, Oral | Sandoz Inc. | ANDA | 0781-3233 | 00781-3233-94 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 1 g/50mL | Injection, Powder, For solutionIntravenous, Oral | Sandoz Inc. | ANDA | 0781-3244 | 00781-3244-94 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 2 g/100mL | Injection, Powder, For solutionIntravenous, Oral | Sandoz Inc. | ANDA | 0781-3255 | 00781-3255-94 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 500 mg/5mL | Injection, Solution, ConcentrateIntravenous | Sandoz Inc | NDA | 0781-3528 | 00781-3528-10 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 1000 mg/10mL | Injection, Solution, ConcentrateIntravenous | Sandoz Inc | NDA | 0781-3529 | 00781-3529-10 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 2000 mg/20mL | Injection, Solution, ConcentrateIntravenous | Sandoz Inc | NDA | 0781-3530 | 00781-3530-10 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 500 mg/25mL | Injection, Powder, For solutionIntravenous, Oral | Baxter Healthcare Company | ANDA | 10019-935 | 10019-0935-01 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 1 g/50mL | Injection, Powder, For solutionIntravenous, Oral | Baxter Healthcare Company | ANDA | 10019-936 | 10019-0936-01 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 2 g/100mL | Injection, Powder, For solutionIntravenous, Oral | Baxter Healthcare Company | ANDA | 10019-937 | 10019-0937-01 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 500 mg/25mL | Injection, Powder, For solutionIntravenous, Oral | Baxter Healthcare Company | ANDA | 10019-938 | 10019-0938-01 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 1 g/50mL | Injection, Powder, For solutionIntravenous, Oral | Baxter Healthcare Company | ANDA | 10019-939 | 10019-0939-01 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 2 g/100mL | Injection, Powder, For solutionIntravenous, Oral | Baxter Healthcare Company | ANDA | 10019-942 | 10019-0942-01 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 500 mg/25mL | Injection, Powder, For solutionIntravenous, Oral | Baxter Healthcare Company | ANDA | 10019-943 | 10019-0943-01 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 1 g/50mL | Injection, Powder, For solutionIntravenous, Oral | Baxter Healthcare Company | ANDA | 10019-944 | 10019-0944-01 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 2 g/100mL | Injection, Powder, For solutionIntravenous, Oral | Baxter Healthcare Company | ANDA | 10019-945 | 10019-0945-01 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 500 mg/25mL | Injection, Powder, For solutionIntravenous, Oral | Baxter Healthcare Company | ANDA | 10019-955 | 10019-0955-01 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 1 g/50mL | Injection, Powder, For solutionIntravenous, Oral | Baxter Healthcare Company | ANDA | 10019-956 | 10019-0956-01 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 2 g/100mL | Injection, Powder, For solutionIntravenous, Oral | Baxter Healthcare Company | ANDA | 10019-957 | 10019-0957-01 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 25 mg/1 | TabletOral | Baxter Healthcare Corporation | NDA authorized generic | 10019-982 | 10019-0982-01 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 50 mg/1 | TabletOral | Baxter Healthcare Corporation | NDA | 10019-984 | 10019-0984-01 | — |
|---|
| Cyclophosphamidecyclophosphamide for injection | Cyclophosphamide 500 mg/25mL | Injection, Powder, For solutionIntravenous | Hainan Poly Pharm. Co., Ltd. | ANDA | 14335-470 | 14335-0470-10 | — |
|---|
| Cyclophosphamidecyclophosphamide for injection | Cyclophosphamide 1 g/50mL | Injection, Powder, For solutionIntravenous | Hainan Poly Pharm. Co., Ltd. | ANDA | 14335-471 | 14335-0471-10 | — |
|---|
| Cyclophosphamidecyclophosphamide for injection | Cyclophosphamide 2 g/100mL | Injection, Powder, For solutionIntravenous | Hainan Poly Pharm. Co., Ltd. | ANDA | 14335-472 | 14335-0472-10 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 200 mg/mL | InjectionIntravenous | Nexus Pharmaceuticals, LLC | ANDA | 14789-125 | 14789-0125-05 | — |
|---|